(February 22, 2016 at 8:15 pm)Exian Wrote: Perhaps it was cheaper to buy the name rather than come up with a generic equal? Perhaps that it was a dormant drug in low demand for so long, acted as a sort of entrance barrier assuring Turing that, even though it wasn't under patent, they could effectively have the monopoly. Even now, nothing is stopping another company from coming up with the generic version and forcing the prices down. Although, Shkreli said they knew going in that they would lose money... hmm.
That's the missing piece. Why would he invest in a drug that doesn't make any money?
If The Flintstones have taught us anything, it's that pelicans can be used to mix cement.
-Homer Simpson
-Homer Simpson